-1366x0.jpg)
With the development of modern medicine, the field of Obstetrics and Gynecology has always been an important specialty for doctors and patients. Over the years, the field of obstetrics and gynecology in Vietnam and provinces across the country has made great strides in terms of scale and level, keeping up with the development of the region and the world.
In order to update new knowledge, the first Congress of Obstetrics and Gynecology in 2023 was solemnly held by Ha Tinh Department of Health in collaboration with Ha Tinh Provincial General Hospital on the afternoon of April 8. This is a scientific forum for doctors, medical professionals, experts to exchange, learn and cultivate clinical knowledge from leading experts, thereby contributing to helping Vietnam's obstetrics and gynecology industry keep up with the development of other countries in terms of expertise and management.
The first Ha Tinh Obstetrics and Gynecology Conference attracted nearly 200 delegates with 4 papers with notable topics such as:
- Studying the effectiveness of Flare-up and Antagonist ovarian stimulation regimens on patients with poor response prognosis in IVF (Dr. Nguyen Anh Tho)
- Comments on the initial treatment of cesarean section scar cases at the Department of Obstetrics and Gynecology, Ha Tinh Province General Hospital (MSc. Nguyen Huu Nhat)
- Actual situation of cesarean section in the hospital of Ha Tinh province (BSCK2. Nguyen Co Thach)
- Evaluating the effectiveness of Nifedipine and Salbutamol in the treatment of threatened preterm labor at Ha Tinh Provincial General Hospital (Dr. Tran Chien Thang)
Delegates at the conference listened and animatedly discussed the topics of obstetrics and gynecology. In addition, many other thematic reports presented by partner units and sponsors were also of the interest of doctors and nurses at Ha Tinh Provincial General Hospital.
Prominent among them is the report of GENTIS company on Cervical cancer screening through HPV (Human Papilloma Virus) test shared by Mr. Nguyen Xuan Bach, Product Manager of GENTIS. At the conference, the representative in charge of GENTIS products raised the dangers of cervical cancer and methods to help screen the disease early to reduce the number of people infected and prevent it for Vietnamese women.
Cervical cancer is the leading cause of cancer death in 36 countries, and the leading cause of death in 23 countries. In Vietnam, cervical cancer is the second most common cancer among genital cancers in women. Every day there are about 14 new cases, including 7 deaths from cervical cancer. This is 2 to 3 times higher than deaths from complications related to pregnancy (pregnancy and childbirth).
The early symptoms of cervical cancer are vague, unclear and will usually only be detected when the disease is advanced at a late stage. However, this disease has a high chance of successful treatment if it is detected and treated properly at an early stage. Therefore, for early detection and prevention of cervical cancer, HPV-DNA testing is recommended for all women over the age of 25 who have had sex at least every 5 years (for women over 25 years of age). negative test result) to screen for cervical cancer.
The HPV-DNA test allows the detection of genetic changes in cervical cells at an early stage, and at the same time helps to assess a woman's risk of HPV infection from low to high to have an appropriate treatment plan. . Up to now, GENTIS is the unit that provides a full set of HPV tests in particular and cervical cancer screening tests in general to many hospitals, centers and clinics across the country.
By testing 40 types of HPV virus from high-risk to low-risk types, the HPV-DNA test at GENTIS has helped doctors to assess the overall health of the disease, and at the same time bring safety. heart and faith for women. As one of the early implementation units of cervical cancer testing in Vietnam, GENTIS company also conducts many counseling and guidance programs for the community to raise awareness about cervical cancer and help people. Know how to prevent and treat diseases effectively.
The report on HPV-DNA testing of GENTIS company also received the consensus of all doctors and nurses at the conference with the desire to have a large-scale screening in the community to repel cervical cancer. In addition to this report, GENTIS also gave doctors at the conference small gifts at the product display booth.
Through gifts and documents sent to doctors, GENTIS hopes to update many new tests to support doctors in the field of Obstetrics and Gynecology. Once again, GENTIS company would like to congratulate the Conference on a great success and look forward to future conferences. GENTIS promises to always ensure the quality of tests and develop many new valuable products to provide to all doctors and nurses nationwide.
